Publicacións en colaboración con investigadores/as de Universidad Politécnica de Valencia (12)

2024

  1. Towards precision medicine of long-acting aripiprazole through population pharmacokinetic modelling

    Psychiatry Research, Vol. 333

2023

  1. AG5 is a potent non-steroidal anti-inflammatory and immune regulator that preserves innate immunity

    Biomedicine and Pharmacotherapy, Vol. 169

  2. Clinical and cost-effectiveness results of an on-call program for pacemaker implantations

    Revista Espanola de Cardiologia, Vol. 76, Núm. 11, pp. 936-937

  3. Correction: A Review of Population Pharmacokinetic Analyses of Linezolid (Clinical Pharmacokinetics, (2022), 61, 6, (789-817), 10.1007/s40262-022-01125-2)

    Clinical Pharmacokinetics

  4. Peripheral modulation of antidepressant targets MAO-B and GABAAR by harmol induces mitohormesis and delays aging in preclinical models

    Nature Communications, Vol. 14, Núm. 1

2022

  1. A Review of Population Pharmacokinetic Analyses of Linezolid

    Clinical Pharmacokinetics, Vol. 61, Núm. 6, pp. 789-817

2021

  1. Identification of ABA Receptor Agonists Using a Multiplexed High-Throughput Chemical Screening

    Methods in Molecular Biology (Humana Press Inc.), pp. 99-111

  2. Review of pharmacokinetics and pharmacogenetics in atypical long-acting injectable antipsychotics

    Pharmaceutics, Vol. 13, Núm. 7

2020

  1. Biofabrication of 3D tumor models in cancer research

    Biomaterials for 3D Tumor Modeling (Elsevier), pp. 67-90

2019

  1. Pharmacokinetics of intravitreal anti-VEGF drugs in age-related macular degeneration

    Pharmaceutics, Vol. 11, Núm. 8

2012

  1. Influence of heart failure on nucleolar organization and protein expression in human hearts

    Biochemical and Biophysical Research Communications, Vol. 418, Núm. 2, pp. 222-228

2009

  1. Prediction of postpartum depression using multilayer perceptrons and pruning

    Methods of Information in Medicine, Vol. 48, Núm. 3, pp. 291-298